Cognitive Impairments in Parkinson's disease

Area of Science:

• Neurology
• Neuroscience
• Clinical Medicine

Background:

• Cognitive impairment is a frequent non-motor symptom in Parkinson's disease (PD).
• The Movement Disorder Society Task Force has established diagnostic criteria for dementia associated with PD (PDD) and mild cognitive impairment in PD (PD-MCI).
• The prevalence of PD, PD-MCI, and PDD is increasing globally.

Purpose of the Study:

• To summarize the current understanding and research progress in cognitive impairment within Parkinson's disease.
• To highlight the importance of established diagnostic criteria for PD-MCI and PDD in advancing research.
• To outline key areas of ongoing investigation in PD-related cognitive disorders.

Main Methods:

• Utilizing the Movement Disorder Society Task Force criteria for PD-MCI and PDD.
• Reviewing existing literature on cognitive impairment in Parkinson's disease.
• Focusing on epidemiological, neurobiological, and clinical research advancements.

Main Results:

• Cognitive deficits in PDD encompass memory, visuospatial, and executive functions.
• Standardized criteria facilitate consistent diagnosis and research across studies.
• Growing patient populations necessitate further research and clinical attention.

Conclusions:

• The established criteria for PD-MCI and PDD are crucial for advancing research.
• Ongoing studies are exploring epidemiology, assessment, neurobiology, biomarkers, prevention, and treatment of cognitive impairment in PD.
• Further research is essential to address the growing burden of cognitive disorders in Parkinson's disease patients.